Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. (Q50797819)

19 March 2018

title

Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. (English)

1 reference

19 March 2018

1 reference

4

1 reference

19 March 2018

Francesca Pentimalli

7

1 reference

19 March 2018

Alfredo Fusco

14

1 reference

19 March 2018

Carlo Maria Croce

13

object named as

Carlo M Croce

1 reference

19 March 2018

Francesco Trapasso

1

1 reference

19 March 2018

Manuela Sarti

2

1 reference

19 March 2018

Rossano Cesari

3

1 reference

19 March 2018

Kristoffel R Dumon

5

1 reference

19 March 2018

Rami I Aqeilan

6

1 reference

19 March 2018

Luisa Infante

8

1 reference

19 March 2018

Hansjuerg Alder

9

1 reference

19 March 2018

Nobutsugu Abe

10

1 reference

19 March 2018

Takashi Watanabe

11

1 reference

19 March 2018

Giuseppe Viglietto

12

1 reference

19 March 2018

publication date

1 September 2004

1 reference

19 March 2018

published in

Cancer Gene Therapy

1 reference

19 March 2018

volume

11

1 reference

19 March 2018

issue

9

1 reference

19 March 2018

page(s)

633-641

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700745

exact match

0 references

cites work

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

HMG domain proteins: architectural elements in the assembly of nucleoprotein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Developmental genetics. Living with bad architecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Thyroid cell transformation requires the expression of the HMGA1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Pancreatic cancer: a review of emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

21 January 2018

Focus on pancreas cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Inhibiting signal transduction: recent advances in the development of receptor tyrosine kinase and Ras inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Pancreatic cancer biology and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

inferred from DOI database lookup

7 January 2021

based on heuristic

High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of pancreatic tumor cell growth in culture by p21WAF1 recombinant adenovirus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700745

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700745

1 reference

19 March 2018

PubMed ID

15272314

1 reference

19 March 2018